Patient Recruitment Case Study: Macrophage Activation Syndrome - Stark / Raving Health
What are you looking for?

Patient Recruitment Case Study: Macrophage Activation Syndrome

A two-cohort, open-label, single arm, multicenter study to evaluate efficacy, safety and tolerability, pharmacokinetics and pharmacodynamics, and immunogenicity of a study drug in children and adults with macrophage activation syndrome (MAS)

Bausch Health Logo

THE CLINICAL TRIAL
Macrophage Activation Syndrome (MAS) is due to an overactive immune system and sometimes described as an entire body inflammatory response. It can cause fever, low blood cell counts, clotting problems, enlargement of the liver and spleen, very high triglyceride levels, and abnormal liver function. The purpose of the Emerald Studies was to see if the investigational drug efficiently reduced the inflammation observed in MAS patients.

 

THE PROJECT
The Sponsor’s goal was to accelerate patient recruitment for this clinical study using a suite of patient recruitment materials developed by the Stark / Raving Health team. The program oversaw a global clinical study with highly specific recruitment criteria. Our approach focused on establishing a unique study brand identity combined with recruitment and educational materials that engaged and empowered patients to consider participation.

Clinical study materials design for rare disease patient recruitment
Clinical study materials design for rare disease patient recruitment
Clinical study materials design for rare disease patient recruitment

Study Materials

An essential element of our approach was the development of materials specifically tailored for Patient Advocacy Groups (PAGs). These materials were designed to support PAGs in conducting educational sessions and raising awareness about the study. From an advocacy perspective, it was crucial that the leaders fully understood the study to effectively present it to patients. Therefore, we kept advocacy group leaders in mind as a primary audience for these materials, ensuring they were well-equipped to disseminate information in an accurate and engaging fashion.

Clinical study materials design for rare disease patient recruitment
Case-Studies-PRA-Emerald-half-width-Desktop-Overview-Presentation

Web Presence

Another pivotal aspect of our strategy was the development of dedicated websites and prescreeners, which provided substantial benefits to both the study teams and participants. The websites functioned as centralized information hubs, offering comprehensive details about the study and ensuring participants had easy access to essential resources. Additionally, the prescreeners streamlined the recruitment process by efficiently identifying eligible participants, thereby saving time and reducing the workload for study teams. This approach not only improved the overall efficiency of the recruitment process but also empowered participants by providing them with clear, accessible information and a straightforward path to enrollment.

Clinical study materials design for rare disease patient recruitment
Clinical study materials design for rare disease patient recruitment

Put our solutions to work for your next clinical trial.

Back Top